Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Cardiology/Vascular Diseases | Endocrinology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Captopril and hydrochlorotiazide

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mylan Laboratories
Approval Status: Approved May 1997
Treatment Area: hypertension

General Information

Captopril and hydrochlorothiazide tablets have been tentatively approved for the treatment of hypertension. Tablets will be manufactured in 25mg/15mg, 50mg/15mg, 25mg/25mg and 50mg/25mg strengths. This antihypertensive product is the generic equivalent of Bristol-Myers Squibb’s capozide. Shipment is scheduled to begin after the Dec. 27, 1997 expiration of Bristol-Myers Squibb’s patent.